Esmolol patient counseling information

Esmolol
BREVIBLOC® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Patient Counseling Information

Physicians should inform patients of the risks associated with BREVIBLOC injection: The most common adverse reactions are symptomatic hypotension ( hyperhidrosis, dizziness ), and asymptomatic hypotension.

References

Adapted from the FDA Package Insert.